İsmail GÜRBAK, Fatih KAHRAMAN, Ahmet Seyda YILMAZ, Hakan DUMAN, Şenol ÇİFTÇİ

Relation of apolipoprotein E gene polymorphism with the severity of coronary artery disease in patients with stable ischemic heart disease

Aim: Atherosclerosis begins from an early age and manifests in later years as Coronary artery disease (CAD). This inflammatory process is aggravated by age, smoking, hypercholesterolemia, hypertension, diabetes mellitus, and genetic factors. We aimed to investigate which isoform of APOE is related to extensive coronary lesions in patients with stable coronary heart disease.Materials and Methods: This study was carried on single center. One hundred and ten patients diagnosed with stable coronary artery disease by coronary angiogram were enrolled consecutively. Syntax score was calculated by a tool of website calculator (www.syntax.com). According to the Syntax score, patients were split into three groups. APOE genotyping was performed through blood samples. Patients split into three groups according to the APOE genotypes: E4 (3/4 and 4/4 genotypes), E3(3/3 genotype), E2 (2/2 and 2/3 genotypes). APOE groups were compared according to baseline characteristics and syntax scores.(%82.6) değil (82.6%) olacak. Lütfen İngilizce kurala göre düzeltiniz. Tüm sayısal değerlerde virgülleri de nokta yapmayı unutmayınız.Results: Coronary angiography and APOE genotypes of 98 patients were analyzed. 81 of patients (%82.6) had E3E3 allele; 6 of patients (%6.1) had E2E3 allele; 10 patients (%10.2) had E3E4 allele and 1 patient (%1) had E2E4 allele. Due to the contrast effect of E2 and E4 on CAD, we excluded patients with E2E4 allele from the study. Firstly, we assessed distribution of APOE genotype E2 (E2E3), E3 (E3E3 and E3E4), E4 (E3E4) within 3 groups of syntax scores. Total of 6 patients of E2 allele was at low syntax score group. 83 patients of E3 allele were at the low-risk group of syntax score. 10 patients of E3 allele were at the mid group and 4 patients were at the high-risk group of syntax score. 7 patients of E4 allele subjects were at the low-risk and 1 patient was at the high-risk group of syntax score. Compared to syntax score groups and APOE genotypes, E2 alleles were in lower syntax score group versus E3 (P=0.046) and E4 (P=0.003) alleles. However E4 alleles were in higher syntax score group versus E3 alleles (P= 0.034). The Syntax score was seemed to be lower in the E2 allele group versus E4 and E2 groups (P=0.013).Conclusion: we reported the first study that E2 allele was related with less and E4 allele was more extensity and severity of CAD in patients with stable ischemic coronary disease.

PDF

___

1. Zhou J, Chen X, Ye H, et al. An association study between genetic polymorphism in the interleukin-6 receptor gene and coronary heart disease. Biomed Res Int 2014;2014:504727.
2. Relationship of Atherosclerosis in Young Men to Serum Lipoprotein Cholesterol Concentrations and Smoking. JAMA 1990;264:3018-24
3. Demirtaş AO, Urgun OD. Can QT interval prolongation or dispersion detected in a positive exercise ECG test predict critical coronary artery disease? Arch Med Sci - Atheroscler Dis 2019;4:7-12.
4. Mi X, Eskridge KM, George V, et al. Structural Equation Modeling of Gene-Environment Interactions in Coronary Heart Disease. Ann Hum Genet. 2011;75:255–65.
5. Preuss M, König IR, Thompson JR, et al. Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study. Circ Cardiovasc Genet. 2010;3:475-83.
6. Roberts R, Stewart AFR. The genetics of coronary artery disease. Curr Opin Cardiol 2012;27:221-7.
7. Roberts R, Stewart AFR. Genes and Coronary Artery Disease. J Am Coll Cardiol. 2012;60:1715-21.
8. Osadnik T, Osadnik K, Pawlas N, et al. Metabolic and genetic profiling of young adults with and without a family history of premature coronary heart disease (MAGNETIC). Study design and methodology. Arch Med Sci 2019;15:590-7.
9. Marrzoq LFA, Sharif FA, Abed AA. Relationship between ApoE gene polymorphism and coronary heart disease in Gaza Strip. J Cardiovasc Dis Res 2011;2:29–35.
10. Larifla L, Armand C, Bangou J, et al. Association of APOE gene polymorphism with lipid profile and coronary artery disease in Afro-Caribbeans. Chiba- Falek O, ed. PLoS One 2017;12:e0181620.
11. Arslan Ince FD, Atay A, Koseoglu M, et al. Relationship between severity of coronary artery disease and apolipoprotein E gene polymorphism. Anadolu Kardiyol Dergisi/The Anatol J Cardiol 2010;10:202-8.
12. Pitsavos C, Choumerianou DM, Skoumas J, et al. Apolipoprotein E polymorphism is not associated with lipid levels and coronary artery disease in Greek patients with familial hypercholesterolaemia. Clin Exp Med 2005;5:196-201.
13. Gamboa R, Huesca-Gómez C, Pérez-Méndez O, et al. Apolipoprotein E polymorphisms in Mexican patients with coronary artery disease. Clin Chem Lab Med 2008;46:481-5.
14. Attila G, Acartürk E, Eskandari G, et al. Effects of apolipoprotein E genotypes and other risk factors on the development of coronary artery disease in Southern Turkey. Clin Chim Acta 2001;312:191-6.
15. Walden CC, Hegele RA. Apolipoprotein E in Hyperlipidemia. Ann Intern Med. 1994;120: 1026–36.
16. McCarron MO, Muir KW, Weir CJ, et al. The Apolipoprotein E ε4 Allele and Outcome in Cerebrovascular Disease. Stroke 1998;29:1882-7.
17. Xu M, Zhao J, Zhang Y, et al. Apolipoprotein E Gene Variants and Risk of Coronary Heart Disease: A Meta- Analysis. Biomed Res Int 2016;2016:1-12.
18. Damani SB, Topol EJ. Emerging Genomic Applications in Coronary Artery Disease. JACC Cardiovasc Interv 2011;4:473-82.
19. Eichner JE, Dunn ST, Perveen G, et. al. Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review. Am J Epidemiol 2002;155:487-95.
20. Sianos G, Morel M-A, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005;1:219- 27.
21. Lorenzo A De, Carazza M, Lima R. All-cause mortality of metabolically healthy or unhealthy obese: risk stratification using myocardial perfusion imaging. Arch Med Sci - Atheroscler Dis 2018;3:90-5.
22. Bulut A, Acele A, Donmez Y, et al. Aortic intimamedia thickness can be used to determine target organ damage in adult patients with coronary artery disease risk factors. Arch Med Sci - Atheroscler Dis 2019;4:183-90.
23. Zhong L, Xie Y-Z, Cao T-T, et al. A rapid and costeffective method for genotyping apolipoprotein E gene polymorphism. Mol Neurodegener 2016;11:2.
24. Singh PP, Singh M, Mastana SS. APOE distribution in world populations with new data from India and the UK. Ann Hum Biol 2006;33:279-308.
25. Mahley RW, Palaoğlu KE, Atak Z, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995;36:839-59.
26. Malle E, Pfeiffer KP, Dugi K, et al. Polymorphisms of apolipoproteins A-IV and E in a Turkish population living in Germany. Hum Genet 1996;98:285-90.
27. Burman D, Mente A, Hegele RA, et.al. Relationship of the ApoE polymorphism to plasma lipid traits among South Asians, Chinese, and Europeans living in Canada. Atherosclerosis 2009;203:192-200.
28. Ford TJ, Corcoran D, Berry C. Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need. Heart 2018;104:284-92.
29. Zhang M, Gu W, Qiao S, et.al. Apolipoprotein E Gene Polymorphism and Risk for Coronary Heart Disease in the Chinese Population: A Meta- Analysis of 61 Studies Including 6634 Cases and 6393 Controls. Aalto-Setala K, ed. PLoS One 2014;9:e95463.
30. Chen Q, Reis SE, Kammerer CM, et al. APOE polymorphism and angiographic coronary artery disease severity in the Women’s Ischemia Syndrome Evaluation (WISE) study. Atherosclerosis 2003;169:159-67.
31. Karahan Z, Uğurlu M, Uçaman B, et al. Relation between Apolipoprotein E Gene Polymorphism and Severity of Coronary Artery Disease in Acute Myocardial Infarction. Cardiol Res Pract 2015;2015:1-4.